Verition Fund Management LLC Invests $251,000 in Semler Scientific, Inc. (NASDAQ:SMLR)

Verition Fund Management LLC acquired a new stake in Semler Scientific, Inc. (NASDAQ:SMLR) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 10,645 shares of the company’s stock, valued at approximately $251,000.

Several other hedge funds and other institutional investors have also made changes to their positions in SMLR. CWM LLC lifted its stake in Semler Scientific by 486.3% in the second quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after acquiring an additional 744 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Semler Scientific by 10.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock valued at $709,000 after purchasing an additional 1,940 shares during the last quarter. Rhumbline Advisers grew its holdings in Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after purchasing an additional 1,320 shares during the period. Quest Partners LLC acquired a new position in Semler Scientific during the second quarter worth approximately $59,000. Finally, Meeder Asset Management Inc. bought a new stake in Semler Scientific in the second quarter valued at approximately $67,000. 49.37% of the stock is owned by institutional investors.

Semler Scientific Trading Down 6.5 %

Shares of NASDAQ SMLR opened at $67.17 on Friday. The company has a market capitalization of $556.77 million, a P/E ratio of 32.77 and a beta of 1.18. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $79.45. The stock has a 50 day moving average of $43.82 and a 200-day moving average of $34.79.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. The firm had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.